Grantham, Mayo, Van Otterloo & Co (GMO)’s Herbalife HLF Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$947K	Buy	+64,332	New	+$1.05M	﹤0.01%	511
2015 Q3	–	Sell	-158,400	Closed	-$4.36M	–	577
2015 Q2	$4.36M	Sell	158,400 -1,200	-0.8%	-$29.1K	0.01%	264
2015 Q1	$3.41M	Sell	159,600 -18,000	-10%	-$307K	0.01%	300
2014 Q4	$3.35M	Sell	177,600 -524,156	-75%	-$11.2M	0.01%	295
2014 Q3	$15.4M	Sell	701,756 -433,800	-38%	-$11.6M	0.04%	171
2014 Q2	$36.6M	Sell	1,135,556 -158,200	-12%	-$4.85M	0.1%	108
2014 Q1	$37M	Sell	1,293,756 -271,400	-17%	-$8.96M	0.1%	106
2013 Q4	$61.6M	Buy	1,565,156 +1,441,994	+1,171%	+$50M	0.15%	87
2013 Q3	$4.3M	Buy	123,162 +15,612	+15%	+$483K	0.01%	332
2013 Q2	$2.43M	Buy	+107,550	New	+$2.29M	0.01%	379

Other funds holding HLF

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HLF Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Herbalife (HLF) in Q1 2026: 64,332 shares worth $947K. The stake represents ﹤0.01% of the portfolio and ranks #511 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in HLF as recently as Q2 2015.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HLF in Q2 2013 and has held it in 10 quarters since. The position peaked at $61.6M in Q4 2013. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 64,332 shares of Herbalife worth $947K as of Q1 2026.
Herbalife was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q1 2026.
Herbalife made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #511 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Herbalife in Q2 2013 and has held it in 10 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Herbalife position peaked at $61.6M in Q4 2013.
252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.